BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

157 related articles for article (PubMed ID: 2195215)

  • 1. [Macroangiopathy and type 2 diabetes mellitus: significance of Diamicron].
    Lesobre B
    Journ Annu Diabetol Hotel Dieu; 1990; ():325-34. PubMed ID: 2195215
    [No Abstract]   [Full Text] [Related]  

  • 2. [Diamicron through the European Association for the Study of Diabetes and the International Diabetes Federation congresses in Sydney in 1988].
    Lesobre B
    Journ Annu Diabetol Hotel Dieu; 1989; ():315-9. PubMed ID: 2668621
    [No Abstract]   [Full Text] [Related]  

  • 3. [Experience with diamicron treatment of diabetics].
    Velikov VK; Shubina IO; Saltykov BB; Frolova AI
    Klin Med (Mosk); 1984 Nov; 62(11):99-101. PubMed ID: 6441072
    [No Abstract]   [Full Text] [Related]  

  • 4. [Diamicron in the treatment of diabetes mellitus type 2].
    Balabolkin MI; Morozova TP; Chachiashvili MV
    Sov Med; 1987; (7):21-2. PubMed ID: 3317910
    [No Abstract]   [Full Text] [Related]  

  • 5. Gliclazide (diamicron) in metabolic and vascular treatment of diabetes mellitus.
    Forette B
    East Afr Med J; 1977 Oct; 54(10):579-81. PubMed ID: 608430
    [No Abstract]   [Full Text] [Related]  

  • 6. [Non-insulin dependent diabetes. Role of gliclazide (diamicron)].
    Lesobre B
    Journ Annu Diabetol Hotel Dieu; 1995; ():313-22. PubMed ID: 7602890
    [No Abstract]   [Full Text] [Related]  

  • 7. [Hypoglycemic agents of the 2d generation].
    Giulietti M
    Clin Ter; 1978 Jul; 86(2):179-81. PubMed ID: 743858
    [No Abstract]   [Full Text] [Related]  

  • 8. Hemobiological properties of gliclazide.
    Ziegler O; Drouin P
    J Diabetes Complications; 1994; 8(4):235-9. PubMed ID: 7833500
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [The effect of diamicron on various blood coagulation indices in patients with type II diabetes mellitus].
    Balabolkin MI; Morozova TP; Zhizhina SA; Novikova NV; Nepsha VD
    Klin Med (Mosk); 1983 Apr; 61(4):66-8. PubMed ID: 6865293
    [No Abstract]   [Full Text] [Related]  

  • 10. [Anti-diabetic treatment, insulin resistance and cardiovascular disease in patients with type 2 diabetes].
    Hemmingsen B; Lund SS; Vaag A
    Ugeskr Laeger; 2009 May; 171(19):1598-602. PubMed ID: 19419642
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Hypoglycemic effect of diamicron in diabetic patients].
    Balabolkin MI; Morozova TP; Zhizhina SA; Gavriliuk LI
    Klin Med (Mosk); 1983 Jan; 61(1):87-9. PubMed ID: 6834765
    [No Abstract]   [Full Text] [Related]  

  • 12. Pathophysiology of vascular disease in diabetes: effects of gliclazide.
    Colwell JA
    Am J Med; 1991 Jun; 90(6A):50S-54S. PubMed ID: 1872305
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Diabetic retinopathy. Effects of gliclazide].
    Lesobre B
    Journ Annu Diabetol Hotel Dieu; 1983; ():275-80. PubMed ID: 6358618
    [No Abstract]   [Full Text] [Related]  

  • 14. [Value of gliclazide in the treatment of early diabetic retinopathy].
    Cabral BV; Fernando R; Villegas-Cinco A; Icasas-Cabral E; Cinco L
    Therapie; 1985; 40(4):231-3. PubMed ID: 4024018
    [No Abstract]   [Full Text] [Related]  

  • 15. From hemobiology to vascular disease: a review of the potential of gliclazide to influence the pathogenesis of diabetic vascular disease.
    Jennings PE
    J Diabetes Complications; 1994; 8(4):226-30. PubMed ID: 7833498
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Increased fibrinolytic potential induced by gliclazide in type I and type II diabetic patients.
    Gram J; Jespersen J
    Metabolism; 1992 May; 41(5 Suppl 1):25-9. PubMed ID: 1574011
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Effect of gliclazide on platelet behavior].
    Verry M; Dechavanne M; Desnoyers P; Stoltz JF; Vainer H
    Nouv Presse Med; 1974 Oct; 3(33):2099-100. PubMed ID: 4471584
    [No Abstract]   [Full Text] [Related]  

  • 18. [The importance of gliclazide in clinical practice].
    Svoboda Z
    Vnitr Lek; 1988 Jun; 34(6):581-5. PubMed ID: 3414038
    [No Abstract]   [Full Text] [Related]  

  • 19. Sulfonylureas and platelet function.
    Klaff LJ; Kernoff L; Vinik AI; Jackson WP; Jacobs P
    Am J Med; 1981 Mar; 70(3):627-30. PubMed ID: 6782875
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Vascular fibrinolytic activity in long term treatment with second generation sulfonylurea compounds.
    Almér LO
    Acta Endocrinol Suppl (Copenh); 1980; 239():53-5. PubMed ID: 6159764
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.